Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.

Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR, Meyuhas O, Shokat KM, Ruggero D.

Cancer Cell. 2010 Mar 16;17(3):249-61. doi: 10.1016/j.ccr.2010.01.021.

2.

Targeting Mnks for cancer therapy.

Hou J, Lam F, Proud C, Wang S.

Oncotarget. 2012 Feb;3(2):118-31. Review.

3.

MAP kinase-interacting kinases--emerging targets against cancer.

Diab S, Kumarasiri M, Yu M, Teo T, Proud C, Milne R, Wang S.

Chem Biol. 2014 Apr 24;21(4):441-452. doi: 10.1016/j.chembiol.2014.01.011. Epub 2014 Mar 6. Review.

4.

Translation factors and ribosomal proteins control tumor onset and progression: how?

Loreni F, Mancino M, Biffo S.

Oncogene. 2014 Apr 24;33(17):2145-56. doi: 10.1038/onc.2013.153. Epub 2013 May 6. Review.

PMID:
23644661

Supplemental Content

Support Center